EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 23.3% of their position (24K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $5.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/18/2026ACC: 0001493152-26-043246
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+24K
Net shares
Net buyer
$5.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
24K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+24K
Price / share
$0.21
Trade value
$4.99K
% of position
23.3%
9/17/2026
102.82K→126.82K
Total
Net shares
+24K
Net value
$4.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/17/2026 | P · Purchase | +24K | $0.21 | $4.99K | 23.3% | 102.82K | 126.82K |
| Total | +24K | $4.99K | ||||||
Derivative Transactions0
No derivative transactions reported